U.S. Markets for Vaccines
Characteristics, Case Studies, and Controversies

  • Title:

    U.S. Markets for Vaccines
  • Format:

    Paperback
  • Paperback Price:

    20.00
  • Paperback ISBN:

    978-0-8447-4280-9
  • Paperback Dimensions:

    6" x 9"
  • 248 Paperback pages
  • Buy the Book

Click here to view the full text as an Adobe PDF.

There is intense interest among scholars and the public about the risks, benefits, and pricing of pharmaceuticals--but relatively little attention has been devoted to vaccine markets and the political, economic, and regulatory factors that influence their development. In this important new study, Ernst R. Berndt, Rena N. Denoncourt, and Anjli C. Warner investigate the key business drivers and challenges of vaccine markets, the complex interactions among their important stakeholders, and the emerging opportunities for growth.

U.S. Markets for Vaccines: Characteristics, Case Studies, and Controversies examines several case studies--including vaccines for diphtheria, tetanus, pertussis, seasonal influenza, chicken pox, and shingles--that demonstrate the diverse dynamics of vaccine markets. The authors consider the role of intellectual property protection in the discovery process, preclinical and clinical development issues, manufacturing and cost characteristics, and the challenges of marketing, product differentiation, pricing, and distribution. They also explore the process of obtaining regulatory approval from the U.S. Food and Drug Administration and earning a spot on the Centers for Disease Control and Prevention's vaccination schedules for pediatric and adult populations. Finally, the authors address the controversial debate over an alleged link between childhood vaccinations and autism.

Drawing upon extensive interviews with representatives from industry, insurance providers, government agencies, health-care providers, and academia, U.S. Markets for Vaccines offers a balanced and comprehensive snapshot of the changing landscape for vaccine markets.

Ernst R. Berndt, PhD, is the Louis E. Seley Professor in Applied Economics at the MIT Sloan School of Management, and a member of the affiliated faculty of the Harvard-MIT Division of Health Sciences and Technology.

Rena N. Denoncourt, MBA, is program manager at Alnylam Pharmaceuticals in Cambridge, Massachusetts.

Anjli C. Warner, MBA, is senior associate, Business Analysis and Information, Amgen, Thousand Oaks, California.

 

 

 

Also Visit
AEIdeas Blog The American Magazine

What's new on AEI

AEI Election Watch 2014: What will happen and why it matters
image A nation divided by marriage
image Teaching reform
image Socialist party pushing $20 minimum wage defends $13-an-hour job listing
AEI on Facebook
Events Calendar
  • 20
    MON
  • 21
    TUE
  • 22
    WED
  • 23
    THU
  • 24
    FRI
Monday, October 20, 2014 | 2:00 p.m. – 3:30 p.m.
Warfare beneath the waves: The undersea domain in Asia

We welcome you to join us for a panel discussion of the undersea military competition occurring in Asia and what it means for the United States and its allies.

Tuesday, October 21, 2014 | 8:30 a.m. – 10:00 a.m.
AEI Election Watch 2014: What will happen and why it matters

AEI’s Election Watch is back! Please join us for two sessions of the longest-running election program in Washington, DC. 

Event Registration is Closed
Wednesday, October 22, 2014 | 1:00 p.m. – 2:30 p.m.
What now for the Common Core?

We welcome you to join us at AEI for a discussion of what’s next for the Common Core.

Thursday, October 23, 2014 | 10:00 a.m. – 11:00 a.m.
Brazil’s presidential election: Real challenges, real choices

Please join AEI for a discussion examining each candidate’s platform and prospects for victory and the impact that a possible shift toward free-market policies in Brazil might have on South America as a whole.

No events scheduled this day.
No events scheduled this day.
No events scheduled this day.
No events scheduled this day.